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Abstract  
Sex-related differences have been observed in the incidence and severity of several 
neurological diseases and in sepsis in humans. Cyclic adenosine monophosphate (cAMP) has 
been shown to play an important role in modulating the inflammatory environment during 
neuroinflammation and importantly in protecting myelin from excitotoxic cell death. 
Considering the sexual dimorphism in the functional properties of oligodendrocytes and the 
importance of a systemic inflammation in the progression of multiple sclerosis, we focused on 
identifying possible sex-related differences in the alterations previously reported for the two 
phosphodiesterase4B (PDE4B) splice-variants (PDE4B2 and PDE4B3) mRNA expression during 
innate neuroinflammation. PDE4A, PDE4B and PDE4D are present in oligodendrocytes and we 
have previously reported that PDE4B3 mRNA is readily expressed in both oligodendrocytes and 
neurons.  
In the present study we analyzed the influence of an intra-peritoneal lipopolysaccharide 
injection on the distribution pattern and expression levels of the PDE4B mRNA splicing variants 
in both male and female mice brains. Clear differences were observed in PDE4B2 and PDE4B3 
mRNA expression levels in males compared to females in a time-dependent manner.  
Furthermore, we observed that the clear downregulation of PDE4B3 mRNA was reflected in a 
lower percentage of oligodendrocytes positive for this transcript which correlated with a 
decrease in inducible cAMP early repressor (ICER) expression in female corpus callosum.  
  
2 
 
Introduction 
Sex-related differences in susceptibility and nature are observed in several neurological 
diseases e.g. Alzheimer’s disease, schizophrenia, depression, stroke, autism and autoimmune 
diseases, like multiple sclerosis (MS) and systemic lupus erythematosus (for reviews see 
(Czlonkowska et al., 2005;Darnall and Suarez, 2009). Approximately 78% of people affected by 
autoimmune diseases are women (Fairweather et al., 2008). Moreover, during innate 
inflammation, women normally respond by more vigorous cellular reaction (for review see 
(Ansar et al., 1985), compared to men who react with higher proinflammatory cytokine 
production, elevating the severity of the innate inflammation  (Marriott et al., 2006). 
Differences have also been observed in the incidence and severity of sepsis in humans 
(Schroder et al., 1998).  
The proinflammatory agent lipopolysaccharide (LPS) is a potent activator of the innate immune 
system. LPS provokes stimulation of complex intracellular signaling pathways activating 
different proinflammatory transcription factors like cyclic adenosine monophosphate (cAMP) 
response element-binding (CREB), activator protein 1(AP-1) and nuclear factor kappa (Kawai et 
al., 2001;Lu et al., 2008).  Sex-related differences are observed in the cytokine response 
towards LPS administration in rodents (Ashdown et al., 2007;Marriott et al., 2006).  
cAMP is involved in the control of the acute inflammatory response, preventing progression to 
a non-beneficial chronic state (for review see (Moore and Willoughby, 1995). cAMP levels are 
regulated by a balance between the activities of two enzymes: adenylyl cyclase and cyclic 
nucleotide phosphodiesterase (PDE) and pharmacological manipulation using specific PDE 
inhibitors, in particular, PDE4 inhibitors provoke profound anti-inflammatory responses (for 
review see (Banner and Trevethick, 2004).  
PDE4 together with PDE7 and PDE8 specifically hydrolyze cAMP in mammals. There is a large 
variety of different variants and splicing forms from the genes (Bender and Beavo, 2006) with 
overlapping properties but with differences in functionality and anatomical distribution (Conti, 
2000;Reyes-Irisarri et al., 2008;Pérez-Torres et al., 2000). These characteristics, together with 
intracellular compartmentalization (Arp et al., 2003) provide several possibilities for selective 
therapeutic targeting.  
cAMP-dependent activation of the CREB cascade initiates transcription of PDE4 (D'Sa et al., 
2002). Especially noteworthy is that LPS phosphorylates CREB in a cAMP- independent manner 
without induction of CREB-dependent transcription (Avni et al., 2010). On the other hand, 
inducible cAMP early repressor (ICER), a potent endogenous repressor of cAMP response 
element (CRE) -mediated gene transcription, can be induced by a variety of stimuli like stress, 
seizure and LPS (for review see (Borlikova and Endo, 2009). 
The alterations of the PDE4B mRNA splice variants in rodent brain in animal models of innate 
neuroinflammation (Johansson et al., 2011) and MS (Reyes-Irisarri et al., 2007) Sanabra, 
Johansson and Mengod, submitted, 2012), combined with both the role of cAMP in protecting 
myelin from excitotoxic cell death (Yoshioka et al., 1998), and the sexual dimorphism in 
neurological diseases prompted us to examine sex-related differences in the PDE4B mRNA 
splice variant expression following LPS administration. We speculate that these enzymes may 
play a role during innate neuroinflammation and consequently also during the initiation and 
relapses of experimental autoimmune encephalomyelitis an animal model of MS by affecting 
the inflammatory environment (Moreno et al., 2011). 
In the present work, we found sex-related differences in the alterations for both PDE4B2 and 
PDE4B3 mRNAs expression in a time-dependent manner. We also show a significant difference 
between male and female in the effect of LPS on the PDE4B3 splice variant mRNA in 
oligodendrocytes correlating with alterations in ICER expression in female.  
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Material and Methods 
Lipopolysaccaride administration  
Adult male and female C57BL6 mice (15-20g) six week old were purchased from Charles River 
Laboratories (France). All experimental procedures followed the European Communities 
Council Directive of November 24, 1986 (86/609/EEC), and were approved by the ethics 
committee of the University of Barcelona and of the Generalitat de Catalunya. Every effort was 
made to minimize the number of animals used and their suffering. The mice were maintained 
on a 12-h light/dark cycle at a constant environmental temperature with free access to food 
and water for one week prior to experimentation. 
A dose-response curve for PDE4B3 mRNA expression was obtained using the following doses 
of LPS in female mice (serotype 055:B5, Sigma-Aldrich, Steinheim, Germany): 0.1, 0.3, 1, 5, 10 
mg/kg (n = 3/dose) dissolved in sterile 0.9% NaCl. A dose-response curve was previously 
obtained in male (Johansson et al., 2011). Based on these curves and in order to obtain 
unambiguous mRNA expression for double in situ hybridization experiments, 10 mg/kg 
bacterial LPS was subsequently administered by an intraperitoneal (i.p.) injection. For 
biochemical experiments the lower dose (5mg/kg) were used. Male mice were euthanized by 
cervical dislocation at 1h, 3h, 8h and 24h (n = 5/time point) after injection for histochemical 
studies and was further compared with previous results (Johansson et al., 2011); at 1h, 3h, 16h 
and 24h (n = 6-10/time point) after injection, from two separate experiments, for biochemistry 
or at 1h, 3h, 8h, 24h and 32h (n = 3-8/time point) after injection, from two separate 
experiments, for cAMP assay. Female mice were euthanized at 1h, 3h, 8h, 24h and 48h 
(n = 8/time point) after injection, from two separate experiments, for histochemistry; and for 
biochemistry and cAMP assay at the same way as reported for male. Controls were made to 
evaluate the effect of the injection with NaCl alone. In the first experiment euthanasia of 
female control-mice were made at 1h, 3h, 8h, 24h and 48h (n = 3/time point), and of male 
control-mice at one single time point (n = 5). In the following experiments cervical dislocation 
of male and female control-mice treated with NaCl alone were made at one single time point. 
Tissue preparation 
Brains were removed immediately, and either the whole brain was rapidly frozen on dry ice 
and stored at -20°C or transferred to ice cold artificial cerebral fluid for dissection of 
leptomeninges and corpus callosum and then frozen on dry ice. The frozen tissue was later 
processed for Western blot and cAMP assay as described below. For in situ hybridization 
histochemistry and staining, 14 μm thick coronal tissue sections of whole brain were cut on a 
microtome-cryostat (Microm HM500 OM, Walldorf, Germany), thaw-mounted onto 3-
aminopropyltriethoxysilane (Sigma-Aldrich)-coated slides, and stored at -20°C until further 
processing. 
Estrous cycle determination 
A sample of cells present in female mice vagina (n=17) was collected with the help of the tip of 
a plastic pipette filled with saline (10μl) at the day of experimentation. The tip was placed 
approximately 1mm into the vagina and repeated flushes with the same solution, three to five 
times, were carried out. The final flush containing vaginal fluid was placed on a glass slide and 
visually observed under light microscope (Zeiss Axioplan, Zeiss, Oberkochen, Germany), the 
sample was then smeared over the slide and dried for staining with Diff-quick (with the kind 
help and scientific advice from Dr. Teresa Ribalta from Anatomía Patológica, Hospital Clínic 
Barcelona (Data not shown)). 
Hybridization probes 
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The oligonucleotide probes complementary to the mRNAs coding for the different PDEs, 
inflammatory and cell markers have previously been published (Johansson et al., 2011). The 
mRNA regions selected for each PDE4B splice variant shared no similarities (Reyes-Irisarri et 
al., 2008). The hybridization conditions used to detect all mRNAs are described elsewhere 
(Miró et al., 2002;Pérez-Torres et al., 2000;Reyes-Irisarri et al., 2005). All oligonucleotides were 
synthesized and then purified by high-performance liquid chromatography (biomers.net 
GmbH, Ulm, Germany and Isogen Bioscience BV, Maarsden, The Netherlands). The specificity 
of the autoradiographic signal obtained in the in situ hybridization histochemistry experiments 
was confirmed by a series of routine controls similar to those previously described (Pompeiano 
et al., 1992).  
Oligonucleotides were labeled at their 3´-end using [α-33P] dATP (3000 Ci/mmol, New England 
Nuclear, Boston, MA, USA) with terminal deoxynucleotidyl-transferase (TdT) (Calbiochem, 
Darmstadt, Germany). All vascular cell adhesion molecule-1 (VCAM-1), glial fibrillary acidic 
protein (GFAP), microtubule-associated protein (MAP2), myelin basic protein (MBP), and 
platelet-activating factor receptor (PAFR) oligonucleotides (100 pmol) were individually non-
radioactively labeled with recombinant TdT (Roche Diagnostics GmbH, Penzberg, Germany) 
and digoxigenin (DIG)-11-dUTP (Boehringer Mannheim, Mannheim, Germany) according to a 
previously described procedure (Schmitz et al., 1991). Labeled probes were purified using 
ProbeQuant G-50 Microcolumns (GE Healthcare, Buckinghamshire, UK). 
In situ hybridization histochemistry 
The protocols for single- and double-label in situ hybridization histochemistry were based on 
previously described procedures (Landry et al., 2000;Tomiyama et al., 1997) and have been 
published elsewhere (Reyes-Irisarri et al., 2007;Serrats et al., 2003). 
For film autoradiography, hybridized sections were exposed to Biomax-MR (Kodak, Rochester, 
NY, USA) films for 2–20 days at -70 °C with intensifying screens. Double in situ hybridized 
sections were treated as described in (Landry et al., 2000). They were exposed in the dark at 4 
°C for 6 weeks, developed in a Kodak D19 (Kodak) developer for 5 min, and fixed in Ilford 
Hypam fixer (Ilford, Mobberly, Cheshire, UK). 
Analysis and preparation of figures from ISHH   
For single in situ hybridization experiments, semi-quantitative measurements of film optical 
densities were conducted using an AIS computerized image system (Imaging Research, St 
Catharines, Ontario, Canada). Sections were stained with cresyl-violet to identify brain 
structures with the aid of the Franklin and Paxinos Mouse Brain Atlas (Franklin and Paxinos, 
2007). The optical densities corresponding to the following regions were measured on 
autoradiograms obtained from coronal tissue sections: Cornu ammonis fields (CA1–2, CA3), 
dentate gyrus (DG), hippocampal fissure (hf), subfornical organ (SFO), caudate putamen (CPu), 
cingulate cortex (Cg), nuclei of the inferior colliculus (IC) and leptomeninges (lepto.).    
First, statistical comparisons using the factors brain region and treatment were carried out by 
separate two-way analyses of variance followed by post hoc Bonferroni’s test for treatment 
and time for each brain region. Then, following normalization to NaCl administration in each 
region statistical comparisons using the factors sex and LPS administration were carried out by 
separate two-way ANOVA followed by post hoc Bonferroni’s test for sex and time point for 
each brain region separately. All statistical analyses were performed using GraphPad Prism 4 
(GraphPad Software, San Diego, CA, USA). Details of the analysis of double in situ hybridization 
experiments are described in Johansson et al. (2011).  
Images from film autoradiograms were obtained using a Wild 420 macroscope (Leica 
Microsystems, Wetzlar, Germany) equipped with a digital camera (DXM1200 F, Nikon, Tokyo, 
Japan) and ACT-1 Nikon software. Microphotography was performed with an Olympus BX51 
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Stereo Microscope (Olympus) equipped with a digital camera (DP71, Olympus, Tokyo, Japan). 
Figures were assembled using Adobe Photoshop (Adobe Systems, San Jose, CA, USA); only 
contrast and brightness were adjusted to optimize images. 
Fluoro-Jade B staining 
The protocol used has previously been published (Johansson et al., 2011). 
Western Blot  
Dissected tissue (corpus callosum and leptomeninges) from control and LPS injected (1h, 3h, 
16h and 24h) mouse brain were homogenized in ice-cold RIPA Buffer with Halt protease 
phosphates inhibitor cocktail (Thermo Scientific, Rockford, IL, USA). Homogenates from 6-10 
animals from each time point after LPS administration and control were examined from two 
separate experiments. 
The protein concentration of each pool was determined with Pierce® BCA Protein Assay Kit 
(Thermo scientific). 20-30 µg of total protein was loaded in each lane separated with 10-12% 
SDS-polyacrylamide gel electrophoresis and transferred to a nitrocellulose or PVDF membrane 
(Bio-Rad, Hercules, CA, USA). The membrane was blocked in 5% non-fat Milk or BSA in TBS / 
0.1 % Tween 20 (TBST) at room temperature for 1h. The antibodies used were: an anti-PDE4B 
polyclonal antibody C-terminal specific (FabGennix Inc., Frisco, TX, USA), anti-CREM (Abcam, 
Cambridge, UK) and the monoclonal antibodies: anti-CREB-1 (Abcam), anti-CREB phospho S133 
(Millipore, CA, USA) and anti-MBP (Abcam). All except for phosphor-CREB were diluted in TBST 
for protein immunoblot analysis and incubated for 1-2h under agitation. Incubation with HRP-
conjugated anti-rabbit IgG (Jackson Immunoresearch Laboratories, PA, USA), anti-mouse IgG 
(Cell Signaling Technology, MA, USA) and anti-rat IgG (AbD Serotec, Oxford, UK) was 
performed for 1-2h. Specific protein bands were revealed with Immuno Star Chemiluminiscent 
Kit (Bio-Rad) or ECL Prime Western Blotting Detection Reagent (GE Healthcare, 
Buckinghamshire, UK). Stripping buffer was used to remove previous antibody staining from 
the membrane. Anti-β-actin (Sigma-Aldrich) immunoblotting was used as loading control. The 
membranes were scanned using Versadoc (Bio-Rad) and the resulting images were analyzed 
and quantified using the associated Quantity One software (Bio-Rad). The intensity of the 
immunoreactive bands from phospho-CREB and the co-migrating ICER-isoforms in each lane 
was corrected against the corresponding intensity of the CREB-stained band, while PDE4B and 
MBP were corrected against β-actin. All experiments were analyzed as duplicates or triplicates, 
only values within the range of 2 standard deviations were included for further analysis. 
Statistical comparisons using the factors sex and LPS administration were carried out by 
separate two-way ANOVA followed by post hoc Bonferroni’s test for sex and time point.  
cAMP Assay 
For cAMP assay, brain hemispheres from LPS administered or control mice were homogenized 
in 5% trichloroacetic acid (TCA) in water (Calbiochem) and the TCA was extracted from the 
sample using water-saturated ether. Samples were stored at -20ºC until processed following 
day. 
The effect of LPS administration on cAMP levels was studied using a cAMP Assay Kit (Cayman, 
Tallinn, Estonia) based on the competition between free cAMP and a cAMP-
acetylcholinesterase conjugate (cAMP-tracer) for a limited number of cAMP-specific rabbit 
antibody binding sites. Protocol and analysis were performed according to manufacturer’s 
instructions. In brief, cAMP concentration (pg cAMP/ml) was calculated by interpolation to 
values (triplicates) determined with known concentrations of cAMP (standard curve) in the 
same assay. The cAMP standard was provided by the manufacturer. After normalization 
statistical comparisons using the factors sex and LPS administration were carried out by 
separate two-way ANOVA followed by post hoc Bonferroni’s test for sex and time point.  
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RESULTS 
Cell survival and neuroinflammatory response 
After staining with Fluoro-Jade B, a small number of necrotic cells were detected in the DG in 
both male and female (Fig. 1A-B), indicating that no severe effects on cell survival aroused 
from the LPS administration at this time point. No other brain region investigated showed 
positive staining. However, as described in previous studies from our laboratory (Johansson et 
al., 2011) a lethality test confirmed that a high LPS dose provoke septic shock at a later time 
point.  
 
Figure 1. Presence of necrotic cells following LPS administration. Photomicrographs were taken from coronal 
sections of the dentate gyrus of animals sacrificed 24h post-injection (10mg/kg). Fluoro-Jade B in male (A) and 
female mouse brain (B). Scale bar =100 µm. 
 
We observed an innate neuroinflammatory response in our animal model upon analysis of 
mRNA alterations of the inflammatory markers; COX-2, IL-1β and VCAM-1 after LPS 
administration. GFAP mRNA expression was used to characterize activation of astrocytes and 
astrogliosis. By visually analyzing images from film autoradiograms a time-dependent response 
in mRNA hybridization levels were observed in both male and female. An increase in 
expression was observed 3h after administration that declined after 24h in both sexes for IL-1β 
and VCAM-1 mRNA (data not shown). The COX-2 mRNA expression also exhibited a common 
peak at this time point for both sexes (Fig. 2B, E) whereas a return to basal expression only 
could be observed in female after 24h (Fig. 2C, F). A moderate upregulation of GFAP mRNA 
was observed 3h after LPS administration in both sexes (Fig. 2H, K) and in contrast to COX-2, 
male showed stronger GFAP expression levels 24h post-injection compared to female (Fig. 2I, 
L). 
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Figure 2.  Expression of COX-2 and GFAP mRNAs in mouse brain following LPS administration. Macroscopic 
photographs of film autoradiograms showing the localization of the mRNAs coding for COX-2 (A-F) and GFAP (G-L) 
following i.p. LPS administration in mouse male and female coronal sections. COX-2 mRNA expression is prominent 
in microvessels (mv) 3h  after LPS administration in both sexes (B, E) and after 24h in male (C) whereas in female a 
return to basal levels is observed at this time point (F). Note the stronger GFAP mRNA hybridization levels in male 
compared to female 24h after LPS (I, L). Control (A, D, G, J) injected saline; LPS (10mg/kg) at 3h (B, E, H, K) and 24 h 
(C, F, I, L). COX-2, cyclooxygenase; GFAP, glial fibrillary acidic protein. Scale bar = 5 mm. 
 
PDE4B2 and PDE4B3 mRNA expression in male and female following acute 
neuroinflammation 
We analyzed by microdensitometry the expression of cAMP-specific PDE4B splice variant 
mRNAs on film autoradiograms obtained after in situ hybridization in mouse brain, comparing 
male and female. The leptomeninges, SFO, IC (consisting of the external cortex, and the 
nucleus of the brachium of the inferior colliculus), Cg (anterior), the hippocampal fissure and 
the hippocampal formation (CA1-3 and DG) (Fig. 3A-C) were selected for measurement of their 
relative optical densities due to their close contact with the brain exterior and consequently 
their possible sensitivity during innate immediate neuroinflammation. We choose to measure 
the IC as an example of the parenchyma proximal to areas in close contact to the 
leptomeninges (Fig. 3C). Consistent with our prior work no alterations were noticed for the 
PDE4B1 or the PDE4B4 splice variant mRNAs expression after LPS administration in neither sex 
(results not shown). However, both PDE4B2 and PDE4B3 splice variants presented alterations 
in mRNA hybridization levels related to both LPS administration and to sex in a time-
dependent manner (Fig. 3).  
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Figure 3.  Alterations in expression of PDE4B2 and PDE4B3 mRNA in mouse brain following LPS administration. 
Effects of LPS administration (10mg/kg)  in different mouse brain areas (A-C) on the mRNA expression of PDE4B 
splice variants PDE4B2 (D) and PDE4B3 (E) 3 and 24h post-injection in male and female. Note the opposite effects 
provoked by LPS on mRNA expression for the two splice variants and the significant difference in downregulation 
observed between male and female for the PDE4B3 mRNA after 24h. Furthermore, a significant downregulation of 
PDE4B3 mRNA expression is shown in the majority of female brain areas at 24h. Data are the mean ± SEM (n = 5 
mice/group). Statistically significant differences between male and female groups after normalization are shown 
with brackets between bars and significant differences in relative optical densities between the LPS-stimulated and 
the control groups in different brain areas are both represented by *P<0.05, **P<0.01, ***P<0.001; Bonferroni 
posttest. CA1-2, CA3, fields of Cornu ammonis; DG, dentate gyrus; hf, hippocampal fissure; SFO, subfornical organ; 
Cg, cingulate cortex; CPu, caudate putamen; IC, nuclei of the inferior colliculus; lept., leptomeninges. 
 
No sex-related variations could be observed between vehicle-administered male and female 
mouse brains in basal PDE4B-splice variant mRNA levels, nor could any differences be noticed 
when comparing control female mice after different saline-treatment time points (1h, 3h, 8h, 
24h, and 48h) (results not shown). The clear difference between sexes in mRNA expression of 
PDE4B3 24h post-injection in all brain areas investigated (Fig. 3E) together with its abundant 
expression in whole brain in control animals (Fig. 4E, 5E) led us to determine the identity of the 
cells expressing this mRNA splice variant (neurons, oligodendrocytes and astrocytes) in the 
parenchyma (IC) (Fig. 3C) and Cg (Fig. 3A). Based on previous reports from our laboratory the 
expression of PDE4B3 mRNA in astrocytes was not investigated in the cingulate cortex 
(Johansson et al., 2011). 
PDE4B2 mRNA expression in male and female following acute neuroinflammation 
Under basal conditions the PDE4B2 mRNA expression was weak in whole mouse brain (Fig. 4A, 
E) except for the hippocampal formations. Already 1h following immune challenge with LPS, 
upregulation of PDE4B2 mRNA levels were clearly observed in leptomeninges (data not shown) 
peaking around 3h post-injection (Fig. 3D, 4B, 4F) in both sexes. This sharp upregulation was 
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also observed 3h after injection in female SFO (Fig. 3D), while in male this appeared only after 
8h (Johansson et al., 2011). Significant upregulation was observed in IC in male after 8h (Fig. 
4C) and in female after 24h (Fig. 3D, 4G). Furthermore, a trend to increased intensity of 
PDE4B2 mRNA expression was observed in various brain areas e.g. the hippocampal areas CA1-
2 and DG 3h post-injection in male differing significantly from female were upregulation was 
observed after 24h (Fig. 3D). The hippocampal fissure, Cg and IC showed a tendency to return 
to control levels 24h post-injection in male, revealing a significant difference compared to 
female which continued to show elevated expression (Fig. 3D, 4D, 4G) only returning to control 
levels around 48h following LPS-administration (Fig. 4H). Caution must be taken when 
comparing the variations in the overall hybridization signal intensity of the same labeled 
oligonucleotide probe from different experiments, observed here for male and female.    
 
Figure 4.  Expression of PDE4B2 mRNA following LPS administration in male and female brains. Macroscopic 
photographs of film autoradiographic images of mouse coronal sections showing alterations in mRNA hybridization 
signal of PDE4B2 in male (A-D) and female (E-H). Control animals (saline i.p.) (A, E); LPS treated animals (10mg/kg 
i.p): 3 h (B, F), 8h (C), 24h (D, G) and 48h (H) after injection. Note the difference in time between male and female in 
the return to basal levels (D, H). Scale bar = 5mm.  
PDE4B3 mRNA expression in male and female following acute neuroinflammation 
PDE4B3 mRNA is abundantly expressed throughout the brain under basal conditions and 
following LPS administration a downregulation in whole brain was revealed in contrast to the 
upregulation observed for PDE4B2 mRNA in specific brain areas. A significant decrease in the 
PDE4B3 mRNA was observed in female in almost all brain areas measured 24h post-injection 
(Fig. 3E, 5G). Furthermore this decrease was also significantly different between sexes (Fig. 3E). 
Additionally, significant differences between sexes were observed in a time-dependent 
manner. An overall trend to PDE4B3 mRNA reduction was observed already 3 and 8h post-
injection in male (Fig 3E, 5B-C) whereas in female the minimum hybridization levels were 
attained 24h after LPS administration (Fig. 3E, 5G). A return towards control densities was 
remarked 24h post-injection in male (Fig. 3E, 5D), and in female this was observed after 48h 
(Fig. 5H). 
 
Figure 5.  Expression of PDE4B3 mRNA following LPS administration in male and female brains. Macroscopic 
photographs of film autoradiographic images of mouse coronal sections showing alterations in mRNA hybridization 
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signal of PDE4B3 in male (A-D) and female (E-H). Control animals (saline i.p.) (A, E); LPS treated animals (10mg/kg 
i.p): 3 h (B, F), 8h (C), 24h (D, G) and 48h (H) after injection.  Note the marked decrease in hybridization levels for 
PDE4B3 mRNA after 24h (G) in female and the return to basal levels 48h after LPS-induced immune response (H). 
Scale bar = 5mm.  
Characterization of cells presenting LPS-altered expression of PDE4B2 and PDE4B3 mRNAs in 
male and female 
The augmented PDE4B2 mRNA expression was associated with an increase in the 
inflammatory cell populations: VCAM mRNA-positive (endothelial cells) and PAFR-mRNA 
positive (microglial/macrophage cells) (data not shown), confirming previous studies from our 
laboratory (Johansson et al., 2011).  
Oligodendrocytes, positive for the mRNA coding for MBP, abundantly (around 70-80%) 
expressed the PDE4B3 splice variant in IC under basal conditions in both sexes (Table 1). The 
downregulation observed for the PDE4B3 mRNA post-injection was localized to 
oligodendrocytes with significantly lower expression after 3h in Cg in male (≈ 55%) and after 
24h in both Cg and parenchyma (IC) in female  (≈ 55, 66%) (Table 1 and Fig. 6B, 6F). The 
number of MBP positive cells counted was constant between control and LPS injected animals 
and western blot studies further confirmed the absence of changes in the amount of MBP 
following LPS administration (data not shown). Figure 6 shows an example of the co-
expression observed in parenchyma between MBP mRNA positive cells and PDE4B3 mRNA in 
male and female following a high LPS dose. Analysis of the presence of PDE4B3 mRNA in the 
neuronal cell population (MAP2 mRNA-positive cells) showed that a relatively constant 
percentage of neurons in both regions expressed this mRNA, with no distinction between 
sexes or time points after LPS injection (Table 1). Following LPS administration PDE4B3 splice 
variant mRNA was also expressed in astrocytes (GFAP mRNA positive cells) (around 30-60%) 
exhibiting no sex-related differences (Table 1). 
 
Table 1. Quantification of the presence of PDE4B3 mRNA in different cellular populations  
 
Quantification was performed in cingulate cortex and nuclei of the inferior colliculus of male and female mice 
sacrificed 3 and 24 h after intra peritoneal LPS administration (10mg/kg) and control animals. Data are the mean 
± SD of 3-5 animals and represent the percentage of counted cells, neurons (MAP2), oligodendrocytes (MBP) and 
astrocytes (GFAP) expressing PDE4B3 mRNA. Each percentage was determined from a mean of 57.7 cells per 
animal, except GFAP positive cells in the cingulate cortex and nuclei of the inferior colliculus of control animals 
where no astrocytes were detected (5999 cells counted). ND, not detected. Statistically significant differences 
between the LPS-stimulated and the control groups in the two brain areas in both male and female are represented 
by *P<0.05, **P<0.01, ***P<0.001; Bonferroni posttest. 
Nuclei of the inferior colliculus
Male Female Male Female
Control 3h 24h Control 3h 24h Control 3h 24h Control 3h 24h
MAP 35 ± 14 43 ± 1 38 ± 8 46 ± 2 41 ± 17 39 ± 7 44 ± 8 35 ± 13 50 ± 12 36 ± 8 43 ± 7 43 ± 11
MBP 80 ± 3 55 ± 13 ** 73 ± 9 83 ± 7 80 ± 6 55 ± 15 *** 71 ± 1 53 ± 6 78 ± 9 86 ± 10 76 ± 4 66 ± 5 *
GFAP ND 53 ± 14 33 ± 13 ND 45 ± 6 45 ± 10
Cingulate Cortex
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Figure 6. LPS-altered expression of PDE4B3 mRNA in oligodendrocytes. Cellular localization of PDE4B3 mRNA in 
oligodendrocytes in male (A-C) and female (D-F) mouse brain parenchyma corresponding to the area of nuclei of 
the inferior colliculus (IC). High-magnification bright-field microphotographs of emulsion-dipped sections, 
simultaneously showing mRNA visualized by double in situ hybridization using 
33
P-labeled oligonucleotides 
complementary to the mRNA coding for PDE4B3 (cluster of dark silver grains), with DIG-labeled oligonucleotides 
(dark precipitate) for MBP mRNA (oligodendrocytes). Control animals (A, D) and LPS treated animals 3 h (B, E) and 
24 h (C, F) after injection. Black arrowheads point to digoxigenin-labeled cells, white arrowheads to radioactively-
labeled cells and double black and white arrowheads to double-labeled cells. Bar = 20m. 
Protein expression in male and female following acute neuroinflammation 
No changes were observed in PDE4B2 or PDE4B3 protein levels neither in male nor in female 
mouse leptomeninges or corpus callosum extracts at any time point following LPS 
administration (data not shown). The ICER protein expression showed a trend to decrease 
already 16h post injection in females being significantly different between sexes after 24h in 
corpus callosum (Fig.7B, C). Noteworthy is the decrease in variability observed at both 16h and 
24h in female compared to all other time points in both sexes (Fig. 7C).  
Phosphorylated CREB protein levels presented a similar expression in both male and female 
corpus callosum following innate immediate neuroinflammation (data not shown). 
 
Figure 7. Alterations in ICER protein expression following LPS administration. Effects of LPS administration on the 
protein expression of ICER in male (A), and female (B) mouse brain dissection of corpus callosum 1, 3, 16 and 24h 
post-injection and control. Graph shows results expressed as percentage of the control protein expression (C). Lines 
represent mean from 2-3 separate experiments with homogenates from each time point, animals are presented as 
grey (male) or black (female) dots (n = 6-10 mice/group). Statistically significant differences between male and 
female are represented by **P<0.01; Bonferroni posttest. 
 
12 
 
cAMP levels following acute neuroinflammation 
Sex-related differences in cAMP levels from whole brain extracts were significant at several 
time points post-injection. In male a trend to higher concentration was noticed, reaching 
maximal levels around 32h post-injection, whereas female showed a decrease at all time 
points following LPS administration (Fig. 8).  
 
 
 
Figure 8. Alterations in cAMP levels in brain following LPS administration. Effects of LPS administration on the 
cAMP levels from male and female mouse brain 1, 3, 8, 24 and 32h post-injection and control. Results are expressed 
as percentage of control cAMP levels from half brain homogenates. Values are mean ± SD of 3 to 8 animals per time 
point, analyzed as triplicates. Statistically significant differences between male and female are represented by 
**P<0.01 and ***P<0.001; Bonferroni posttest. 
 
DISCUSSION  
This study deals with the importance of sex differences in brain research and endorses 
previous reports of sexual dimorphism in the innate inflammatory response. We aimed to 
determine whether there where basic sex differences in the alterations previously revealed in 
PDE mRNA expression in an animal model of innate neuroinflammation.  
The possible influence of the reproductive cycle of the females used in the present work on 
the PDE4B splice variants expression was excluded considering the following: i) No alterations 
of PDE4B mRNAs were observed at different time points in control females (from 1h until 48h). 
ii) Similar variability of the data was obtained in male and female specimen. iii) We could 
discern different stages of the estrous cycle for the females investigated via vaginal smears. 
Together, these factors suggest that the reproductive state probably has no influence on the 
results presented here, as recently proposed (McCarthy et al., 2012). Given the fact that the in 
vivo experiments were conducted during daytime we can exclude the influence of the 
circadian cycle in the expression levels of PDE4B splice variants as described by Kim and 
coworkers (Kim et al., 2007). 
We found that the PDE4B splice variants mRNA expression differ in male and female brains 
during an innate immune response induced by a high peripheral LPS dose, revealing a 
resemblance to variations normally reported for inflammatory markers. The elevated 
expression observed for COX-2 mRNA in males and not in females 24h post-injection confirms 
the generally higher production of cytokines and COX-2 reported in male mice (Ashdown et al., 
2007;Marriott et al., 2006). Furthermore, higher GFAP mRNA expression suggests a stronger 
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innate immune response in males in accordance with the reported sex-related differences in 
severity of sepsis (Marriott et al., 2006;Schroder et al., 1998). The timing of the PDE4B2 and 
PDE4B3 mRNA responses show sexual dimorphism as male mice present a peak in PDE4B2 
expression around 8h in specific brain areas compared to the female peak observed after 24h. 
This, together with the return to control expression levels for both mRNAs, which in females 
occurs later than in males, agree with a later cytokine response in female mice (Gregory et al., 
2000).  Although the cytokine response during inflammation clearly differs between male and 
female, the differences in intensity and timing reported throughout the literature depend on 
many factors, including the disease model, species, area of investigation (Klingstrom et al., 
2008;Murakami and Ono, 1987;Pitychoutis et al., 2009;Santos-Galindo et al., 2011). The higher 
numbers of the toll-like receptor (TLR)-4 - CD14 complex on macrophage cell surface and of 
LPS binding protein present during basal conditions in the male brain (Marriott et al., 2006) 
might result in the earlier inflammatory response to LPS administration we described here in 
male mice brain.  
PDE4B2 mRNA is mainly localized in microglia and endothelial cells and PDE4B3 mRNA is 
expressed in oligodendrocytes (Olgs) and neurons, as we have previously described (Johansson 
et al., 2011). Olgs are known to be sensitive to cytokine release showing apoptosis and myelin 
damage (Cai et al., 2003;D'Souza et al., 1996) and, a decline in the oligodendrocytic cell 
population might provoke the observed downregulation of PDE4B3 transcript in these cells. 
However, a more plausible explanation might be by repression of PDE4B3 transcription since i) 
no apoptotic or necrotic cells were found, and ii) the amount of MBP-mRNA positive cells and 
the MBP protein expression were preserved following LPS administration. The low expression 
of TLR-4 on Olgs suggests (Lehnardt et al., 2002) that other pathways activated by 
inflammatory cytokines might be responsible for such transcriptional repression.  
ICER is a potent endogenous repressor of CRE-mediated gene transcription, ubiquitously 
expressed in glia (Kell et al., 2004) and is therefore, a possible candidate responsible for the 
LPS induced PDE4B3 mRNA downregulation. However, in contrast to our working hypothesis 
that an increase in ICER would lead to repression of PDE4B3 transcription, we observed a 
decrease in ICER protein expression in female. The decrease in variability observed in ICER 
protein expression in females further supports a connection between LPS and ICER, 
comparable to that observed between LPS and PDE4B3 mRNA expression. Furthermore, no 
alterations were observed in the two PDE4B splice variants protein expression in either sex, 
suggesting higher PDE activity in female compared to male mice, coherent with the decreased 
cAMP concentrations observed in females. Decreased ICER expression might reflect a 
systematic attempt to increase PDE4B3 expression as a mean to recover the low cAMP levels, 
a possible explanation that deserves further investigation.  
The sex hormones, estrogens and testosterone are thought to mediate several of the sex 
related differences in the immune response (Fairweather et al., 2008;Marriott et al., 2006). 
Interestingly, the promoters of typical proinflammatory cytokine genes lack estrogen response 
elements and alternative explanations have been suggested for estrogen-dependent inhibition 
of cytokine transcription (Pottratz et al., 1994). For example, tumor necrosis factor-α (TNF-α) 
inhibition provoked by modulation of the AP-1 promoter has been explained by an estrogen-
dependent decrease in upstream regulators of AP-1 binding (Srivastava et al., 1999). On the 
other hand, TNF signaling has been proven to activate the transcription factor AP-1 in glial cells 
(Rothe et al., 1994). Studies on the PDE4D genome revealed the presence of AP-1 binding site 
in the PDE4 promoter (Vicini and Conti, 1997) leaving both the estrogen and cytokines as other 
plausible regulators of the LPS-induced PDE4B mRNA alterations worth investigating.  
The decrease in cAMP levels we observed in females, is relevant in view of the participation of 
this second messenger in the remyelization process that takes place  following white matter 
damage as observed in multiple sclerosis  (for review see (Chari, 2007)) and also in the 
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protection of myelin from exocytosis  (Yoshioka et al., 1998). In conclusion, we propose that 
the endogenous PDE4B3 mRNA downregulation observed in female brain could influence the 
effect of the acute neuroinflammation on oligodendrocytes, providing a possible explanation 
to their differential susceptibility to demyelinating diseases. 
The extensive variation between sexes in the inflammatory response underlines the 
importance of sex-related investigation in order to understand the biology of neurological 
diseases in women and to improve pharmacological treatments of such diseases. It is also 
worth considering that many biochemical sex differences observed might be a reflection of a 
compensatory mechanism that ultimately makes males and females more similar (De Vries, 
2004). The results presented here imply that manipulation of PDE activity requires sex specific 
investigation and further emphasize the issue of sexual bias in animal research studies. 
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